Pharmacists across all settings have noted positive impacts of the Additional Roles Reimbursement Scheme (ARRS), but community pharmacists said ‘too many’ pharmacists had moved into general practice - an exclusive survey has shown.
Around three-quarters of around 100 pharmacists working across community, general practice, primary care networks (PCNs) and hospitals said that the scheme has had a positive impact on patients, pharmacists and GP practices, according to a snapshot survey run in conjunction with our sister titles Healthcare Leader and Pulse PCN.
| The impact of ARRs on: | Very positive | Positive | Neutral | Negative | Very negative | Don't know | Not applicable |
| GP practice staff | 30% | 44% | 14% | 4% | 0% | 3% | 4% |
| Your GP practice (as your place of work) | 34% | 38% | 12% | 2% | 0% | 2% | 11% |
| Your patients | 31% | 45% | 12% | 4% | 0% | 3% | 4% |
| Your profession | 33% | 41% | 10% | 7% | 5% | 1% | 3% |
The ARRS scheme was introduced in 2019 and enables PCNs to claim funding for additional roles within general practice, including pharmacists and pharmacy technicians.
Pharmacists are still the most popular ARRS role hired by PCNs. In April 2024, there were 5,308 full time equivalent (FTE) ARRS pharmacists working in PCNs.
Eight in 10 of all pharmacists surveyed said they thought the scheme had improved patient access, while 86% said the scheme had improved patient care.
But further questions found much higher opposition to ARRS from community pharmacists. One in three (30%) said they felt either negatively or very negatively about the scheme’s impact on the pharmacist profession.
Only 33% of the 31 community pharmacists responding to the survey said that as a result of ARRS pharmacists, general practice now had a better understanding of community pharmacy challenges. Meanwhile, 42% said it did not.
However, 59% of the 25 non-ARRS general practice pharmacists that responded thought the ARRS scheme had improved general practice’s understanding of community pharmacy challenges.
Some 36% of community pharmacy respondents said that ARRS roles had resulted in pharmacy closures, while 32% said it had not.
The majority (70%) of community pharmacists said that ‘too many’ pharmacists had moved from community pharmacy into general practice resulting in workforce shortage.
This view was shared by 46% of non-ARRS general practice pharmacists.
Meanwhile, 36% of community pharmacists said the introduction of PCN ARRS pharmacy roles had had a positive impact on their work, while 36% also said it had not.
Over half (54%) of non-ARRS general practice pharmacists agreed that ARRS roles had had a positive impact on their work, while 33% neither agreed nor disagreed, and 13% disagreed.
Liam O’Sullivan, a community pharmacist in Southampton, told our sister title Pulse PCN that he had seen many of his colleagues move into PCN roles.
The shift had meant those working in community pharmacy had less opportunity to gain prescribing qualifications, he said.
With newer pharmacists now coming out of university with independent prescribing skills, this was causing concern.
He said: ‘I am unable to get GP support for a prescribing qualification. I have other colleagues who are travelling far to get supervision requirements. The government needs to really push support for current community pharmacists who are eager to qualify before newly qualified pharmacists can “jump the queue” despite having less experience.’
But he also noted that some PCN pharmacists have had difficulty getting support for training. ‘If even employing pharmacists under ARRS is not enough incentive to invest the proper time in mentoring, I’m not sure what the answer is.’
And Tase Oputu, England board chair of the Royal Pharmaceutical Society (RPS), commented that ARRS pharmacists had 'made a huge difference for patients'.
'With continued pressures on the health service, we need a strategic approach to workforce planning across the system, backed by the ongoing investment needed to deliver high-quality patient care,' she added.
The snapshot survey was run in conjunction with our sister titles Healthcare Leader and Pulse PCN. It ran online from 29 April to 20 May 2024. The total 1,793 respondents included 31 community pharmacists, 44 pharmacists in an ARRS role, 25 non-ARRS GP pharmacists and 14 hospital pharmacists.
It also revealed that pharmacists across both community and general practice / PCN pharmacy are united in wanting support for community pharmacy to be a top priority for the next government.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.